Franklin Resources
KRTX

Franklin Resources’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Franklin Resources’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,488
Closed -$39.7M – 2984
2023
Q4 		$39.7M Sell
125,488
-77,663
-38% -$15.1M 0.02% 573
2023
Q3 		$34.4M Sell
203,151
-179
-0.1% -$33.7K 0.02% 600
2023
Q2 		$44.1M Buy
203,330
+6,785
+3% +$1.45M 0.02% 561
2023
Q1 		$35.7M Buy
196,545
+45
+0% +$8.61K 0.02% 626
2022
Q4 		$38.6M Sell
196,500
-412
-0.2% -$88.3K 0.02% 597
2022
Q3 		$44.3M Sell
196,912
-53,367
-21% -$10.8M 0.02% 555
2022
Q2 		$31.7M Buy
250,279
+22,615
+10% +$2.6M 0.02% 683
2022
Q1 		$28.9M Buy
227,664
+14,164
+7% +$1.59M 0.01% 755
2021
Q4 		$28M Buy
213,500
+4,800
+2% +$620K 0.01% 802
2021
Q3 		$25.5M Buy
208,700
+800
+0.4% +$92.3K 0.01% 835
2021
Q2 		$23.7M Buy
207,900
+8,000
+4% +$935K 0.01% 824
2021
Q1 		$24M Buy
+199,900
New +$22.6M 0.01% 794

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Franklin Resources's KRTX Position: Q1 2024 in Review

Franklin Resources sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 125,488 shares — an estimated $39.7M sold.

Franklin Resources first reported a position in KRTX in Q1 2021 and held it in 12 quarters. The position peaked at $44.3M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Franklin Resources reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Franklin Resources sold 125,488 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $39.7M.
  • Franklin Resources first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Franklin Resources's Karuna Therapeutics, Inc. Common Stock position peaked at $44.3M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Franklin Resources's 13F filing for Q1 2024, filed 13 May 2024.